支气管切除症患者的气道清除管理:来自欧洲支气管切除症注册表 (EMBARC) 的数据
Arietta Spinou1,2,3, Beatriz Hererro-Cortina4,5,6,3, Stefano Aliberti7,8
1Population Health Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
The European respiratory journal
|April 12, 2024
概括
只有一半的欧洲支气管切除症患者使用气道清除管理,尽管国际建议. 在整个欧洲,特别是东部地区,对胸部物理治疗等治疗方法的获取是有限的.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 临床研究 临床研究
背景情况:
- 国际指导方针提倡在支气管切除症治疗中进行气道清除管理.
- 目前在欧洲支气管切除症患者中使用气道清除的情况在很大程度上仍未得到量化.
- 这项研究解决了欧洲各地了解空气通道清理实践的差距.
研究的目的:
- 确定欧洲支气管切除症患者中气道清除管理的流行率.
- 确定影响使用气道空隙的因素.
- 评估空气通道清除技术,设备和粘液活性药物的可用性.
主要方法:
- 使用欧洲多中心支气管切开症审计和研究合作 (EMBARC) 注册表进行前性观察研究.
- 从2015年1月到2022年4月收集的数据.
- 包括来自28个欧洲国家的16723名支气管切除症患者.
主要成果:
- 52%的参与者报告了定期的气道清除管理.
- 经常报告的是活跃循环呼吸技术 (28%) 和气道清除装置 (16%).
- 在各个国家观察到呼吸道清除使用和获得专业物理治疗的显著差异,东欧的获取率较低.
- 使用呼吸道清除管理的患者表现出更严重的疾病严重程度和症状.
结论:
- 大约一半的欧洲支气管切除症患者未充分利用气道清除管理.
- 在许多欧洲国家,使用气道清除装置,粘液活性药物和专业呼吸器物理治疗是受限制的.
- 需要进一步努力,以改善在欧洲各地的支气管切除症患者获得和遵守气道清除管理.
相关概念视频
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.8K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:26COPD: Management Using Bronchodilators and Corticosteroids
198
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
198
01:24Cystic Fibrosis: Management
158
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
158
01:30Asthma-IV: Nursing Management
3.1K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.1K
01:17Drugs Used in Lower Respiratory Disorders: Overview
428
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
428